Concentra reported preliminary unaudited financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2025. For Q4 2025, Concentra expects revenue of USD 539.1 million and net income of USD 36.2 million. Net income attributable to shareholders is USD 34.7 million, with adjusted net income attributable to shareholders at USD 36.1 million. Earnings per share is USD 0.27, and adjusted earnings per share is USD 0.28. Adjusted EBITDA stands at USD 95.3 million. Patient visits in the quarter total 3,264,322, with revenue per visit at USD 149.63. Capital expenditures amount to USD 20.2 million. For FY 2025, Concentra expects revenue of USD 2.16 billion, up 13.9 percent. Net income is USD 172.8 million, and net income attributable to shareholders is USD 166.4 million. Adjusted net income attributable to shareholders is USD 176.0 million. Earnings per share is USD 1.30, and adjusted earnings per share is USD 1.37. Adjusted EBITDA is USD 431.9 million, representing a 14.6 percent increase. The company reports repurchases of approximately 1.1 million shares of common stock totaling USD 22.4 million. Total occupational health centers at year-end are 628, and total onsite health clinics are 411.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Concentra Group Holdings Parent Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260128352464) on January 28, 2026, and is solely responsible for the information contained therein.